Agendia’s BluePrint Included in German Oncology Group Guidelines
By Karen Roman Agendia, Inc.’s BluePrint was recently included in the latest version of German...
By Karen Roman Agendia, Inc.’s BluePrint was recently included in the latest version of German...
By Daniella Parra Gameto, a female-led biotechnology firm, said it received tentative FDA approval to...
By Karen Roman Orthobond Corp. said the Food and Drug Administration approved its request to...
By Karen Roman Acumen Pharmaceuticals, Inc. (Nasdaq: ABOS), a clinical-stage biopharmaceutical company, announced it signed...
By Daniella Parra Gameto, a biotech firm focused on women’s healthcare, shared a study examining...
By Karen Roman REGENXBIO Inc. (Nasdaq: RGNX), a clinical-stage biotechnology company, said its subretinal treatment...
By Karen Roman Agendia, Inc., a biotechnology company that provides molecular diagnostics and cancer treatment,...
By Daniella Parra Conduit Pharmaceuticals Inc. (Nasdaq: CDT) announced the appointment of Dr. Joanne Holland...
By Karen Roman Conduit Pharmaceuticals Inc. (Nasdaq: CDT), a clinical-stage life science company, reported it...
By Daniella Parra Promontory Therapeutics Inc. completed enrollment of 109 late-stage metastatic castration-resistant prostate cancer...